The trademark application AMLYPAVE was filed by Alexion Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 29, 2022, and it was registered by office on September 5, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 10, 2023. Appointment and Replacement of representative of the trademark registration was recorded on April 9, 2024.